Risk factors for late pulmonary homograft stenosis after the Ross procedure

被引:53
作者
Raanani, E
Yau, TM
David, TE
Dellgren, G
Sonnenberg, BD
Omran, A
机构
[1] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Dept Surg,Div Cardiovasc Surg, Toronto, ON M5G 2C4, Canada
[2] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Dept Surg,Div Cardiol, Toronto, ON M5G 2C4, Canada
[3] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Dept Med,Div Cardiol, Toronto, ON M5G 2C4, Canada
[4] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Dept Med,Div Cardiovasc Surg, Toronto, ON M5G 2C4, Canada
关键词
D O I
10.1016/S0003-4975(00)01905-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. We reviewed our experience with the Ross procedure to identify the prevalence and predictors of late pulmonary homograft stenosis. Methods. between June 1992 and December 1997, 109 consecutive patients (age 34.5 +/- 8.6 years) underwent the Ross procedure, with reconstruction of the right ventricular outflow tract with a cryopreserved pulmonary homograft (22 to 30 mm diameter). There was one early and one late death. Echocardiographic follow-up was available in 105 of 108 patients (97%), with a follow-up of 39 +/- 20 months. Homograft donor and preservation measurements and patient variables were subjected to multivariable analyses to identify independent predictors of late homograft performance. Results. The major physiopathologic finding was homograft stenosis. Peak systolic gradients across the homograft were 20 mm Hg or more in 30 of 105 patients (28.5%) and 40 mm Hg or more in 4 of 105 patients (3.8%). One patient required two re-replacements of her homograft for severe stenosis. Moderate or severe homograft insufficiency was noted in 10 of 105 patients (9.5%). The independent predictors of late pulmonary homograft stenosis were younger donor age (p = 0.03), shorter duration of cryopreservation (p = 0.01), and smaller homograft size (p = 0.06). Beating heart donor status, short homograft ischemic time, and other factors that have been shown to be associated with increased graft viability were associated with graft stenosis but did not reach statistical significance. However, mean gradients across the homograft were significantly related (p 0.002) to the number of these risk factors in each patient. Conclusions. Stenosis of the pulmonary homograft can be a significant problem following the Ross procedure, and was predicted by younger donor age and shorter duration of cryopreservation. These factors may be related to increased cellular viability, which might actually predispose to late homograft stenosis in a subgroup of patients. (Ann Thorac Surg 2000;70:1953-7) (C) 2000 by The Society of Thoracic Surgeons.
引用
收藏
页码:1953 / 1957
页数:5
相关论文
共 21 条
  • [1] EFFECTS OF ANTIFUNGALS ON THE VIABILITY OF HEART-VALVE CUSP DERIVED FIBROBLASTS
    AGUIRREGOICOA, V
    KEARNEY, JN
    DAVIES, GA
    GOWLAND, G
    [J]. CARDIOVASCULAR RESEARCH, 1989, 23 (12) : 1058 - 1061
  • [2] ALBERT JD, 1993, J THORAC CARDIOV SUR, V106, P228
  • [3] VIABILITY STUDIES OF HUMAN VALVES PREPARED FOR USE AS ALLOGRAFTS
    ARMIGER, LC
    [J]. ANNALS OF THORACIC SURGERY, 1995, 60 (02) : S118 - S121
  • [4] Tissue engineering of heart valves - human endothelial cell seeding of detergent acellularized porcine valves
    Bader, A
    Schilling, T
    Teebken, OE
    Brandes, G
    Herden, T
    Steinhoff, G
    Haverich, A
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1998, 14 (03) : 279 - 284
  • [5] Chambers JC, 1997, CIRCULATION, V96, P2206
  • [6] PREIMPLANTATION ALTERATION OF ADENINE-NUCLEOTIDES IN CRYOPRESERVED HEART-VALVES
    DOMKOWSKI, PW
    MESSIER, RH
    CRESCENZO, DG
    ALY, HS
    ABDELFATTAH, AS
    HILBERT, SL
    WALLACE, RB
    HOPKINS, RA
    [J]. ANNALS OF THORACIC SURGERY, 1993, 55 (02) : 413 - 419
  • [7] LANG SJ, 1994, J THORAC CARDIOV SUR, V108, P63
  • [8] ADENINE-NUCLEOTIDE DEPLETION IN CRYOPRESERVED HUMAN CARDIAC VALVES - THE STUNNED LEAFLET INTERSTITIAL CELL-POPULATION
    MESSIER, RH
    DOMKOWSKI, PW
    ALY, HM
    JONES, JL
    HILBERT, SL
    CRESCENZO, DG
    ABDELFATTAH, AS
    WALLACE, RB
    BASS, BL
    HOPKINS, RA
    [J]. CRYOBIOLOGY, 1995, 32 (03) : 199 - 208
  • [9] Increased pulmonary flow velocities in oversized homografts in patients after the Ross procedure
    Moidl, R
    Simon, P
    Kupilik, N
    Chevtchik, O
    Heinrich, N
    Moritz, A
    Wolner, E
    Laufer, G
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1997, 12 (04) : 569 - 572
  • [10] Cryopreserved homograft valves in the pulmonary position: Risk analysis for intermediate-term failure
    Niwaya, K
    Knott-Craig, CJ
    Lane, MM
    Chandrasekaren, K
    Overholt, ED
    Elkins, RC
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1999, 117 (01) : 141 - 146